223 related articles for article (PubMed ID: 28803389)
1. Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome.
Arora M; Bagi P; Strongin A; Heimall J; Zhao X; Lawrence MG; Trivedi A; Henderson C; Hsu A; Quezado M; Kleiner DE; Venkatesan AM; Holland SM; Freeman AF; Heller T
J Clin Immunol; 2017 Oct; 37(7):695-700. PubMed ID: 28803389
[TBL] [Abstract][Full Text] [Related]
2. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
[TBL] [Abstract][Full Text] [Related]
3. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
[TBL] [Abstract][Full Text] [Related]
4. Coronary atherosclerosis and dilation in hyper IgE syndrome patients: Depiction by magnetic resonance vessel wall imaging and pathological correlation.
Abd-Elmoniem KZ; Ramos N; Yazdani SK; Ghanem AM; Holland SM; Freeman AF; Gharib AM
Atherosclerosis; 2017 Mar; 258():20-25. PubMed ID: 28167354
[TBL] [Abstract][Full Text] [Related]
5. Dupilumab for STAT3-Hyper-IgE Syndrome With Refractory Intestinal Complication.
Lu CW; Lee WI; Chung WH
Pediatrics; 2021 Sep; 148(3):. PubMed ID: 34417287
[TBL] [Abstract][Full Text] [Related]
6. Life-Threatening Pneumopathy and
Deverrière G; Lemée L; Grangé S; Boyer S; Picard C; Fischer A; Marguet C
Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562253
[TBL] [Abstract][Full Text] [Related]
7. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
8. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
[TBL] [Abstract][Full Text] [Related]
9. Bone density and fractures in autosomal dominant hyper IgE syndrome.
Sowerwine KJ; Shaw PA; Gu W; Ling JC; Collins MT; Darnell DN; Anderson VL; Davis J; Hsu A; Welch P; Puck JM; Holland SM; Freeman AF
J Clin Immunol; 2014 Feb; 34(2):260-4. PubMed ID: 24402620
[TBL] [Abstract][Full Text] [Related]
10. Eosinophilia and reduced STAT3 signaling affect neutrophil cell death in autosomal-dominant Hyper-IgE syndrome.
Farmand S; Kremer B; Häffner M; Pütsep K; Bergman P; Sundin M; Ritterbusch H; Seidl M; Follo M; Henneke P; Henriques-Normark B
Eur J Immunol; 2018 Dec; 48(12):1975-1988. PubMed ID: 30315710
[TBL] [Abstract][Full Text] [Related]
11. Coronary artery abnormalities in Hyper-IgE syndrome.
Freeman AF; Avila EM; Shaw PA; Davis J; Hsu AP; Welch P; Matta JR; Hadigan C; Pettigrew RI; Holland SM; Gharib AM
J Clin Immunol; 2011 Jun; 31(3):338-45. PubMed ID: 21494893
[TBL] [Abstract][Full Text] [Related]
12. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
Xie L; Hu X; Li Y; Zhang W; Chen L
Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
[TBL] [Abstract][Full Text] [Related]
13. Severe eczema and Hyper-IgE in Loeys-Dietz-syndrome - contribution to new findings of immune dysregulation in connective tissue disorders.
Felgentreff K; Siepe M; Kotthoff S; von Kodolitsch Y; Schachtrup K; Notarangelo LD; Walter JE; Ehl S
Clin Immunol; 2014 Jan; 150(1):43-50. PubMed ID: 24333532
[TBL] [Abstract][Full Text] [Related]
14. The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome.
Yanagimachi M; Ohya T; Yokosuka T; Kajiwara R; Tanaka F; Goto H; Takashima T; Morio T; Yokota S
J Clin Immunol; 2016 Jul; 36(5):511-6. PubMed ID: 27091139
[TBL] [Abstract][Full Text] [Related]
15. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China.
Zhang LY; Tian W; Shu L; Jiang LP; Zhan YZ; Liu W; Zhao XD; Cui YX; Tang XM; Wang M; Wu DQ; Yang XQ
Scand J Immunol; 2013 Sep; 78(3):258-65. PubMed ID: 23659370
[TBL] [Abstract][Full Text] [Related]
16. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
[TBL] [Abstract][Full Text] [Related]
17. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
Chandesris MO; Melki I; Natividad A; Puel A; Fieschi C; Yun L; Thumerelle C; Oksenhendler E; Boutboul D; Thomas C; Hoarau C; Lebranchu Y; Stephan JL; Cazorla C; Aladjidi N; Micheau M; Tron F; Baruchel A; Barlogis V; Palenzuela G; Mathey C; Dominique S; Body G; Munzer M; Fouyssac F; Jaussaud R; Bader-Meunier B; Mahlaoui N; Blanche S; Debré M; Le Bourgeois M; Gandemer V; Lambert N; Grandin V; Ndaga S; Jacques C; Harre C; Forveille M; Alyanakian MA; Durandy A; Bodemer C; Suarez F; Hermine O; Lortholary O; Casanova JL; Fischer A; Picard C
Medicine (Baltimore); 2012 Jul; 91(4):e1-e19. PubMed ID: 22751495
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous Gastrointestinal Perforations in STAT3-Deficient Hyper-IgE Syndrome.
Bhattacharya S; Williamson H; Urban AK; Heller T; Freeman AF
J Clin Immunol; 2020 Nov; 40(8):1199-1203. PubMed ID: 32915432
[No Abstract] [Full Text] [Related]
19. Lung disease in STAT3 hyper-IgE syndrome requires intense therapy.
Kröner C; Neumann J; Ley-Zaporozhan J; Hagl B; Meixner I; Spielberger BD; Dückers G; Belohradsky BH; Niehues T; Borte M; Rosenecker J; Kappler M; Nährig S; Reu S; Griese M; Renner ED
Allergy; 2019 Sep; 74(9):1691-1702. PubMed ID: 30793327
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
